Valuation Procyon Corporation

Stocks

Delayed OTC Markets 22:26:01 27/10/2026 +03			5-day change	1st Jan Change
0.1800 ^USD	-2.70%		-.--%	+48.76%

26/10/24	Procyon Corporation Reports Earnings Results for the Full Year Ended June 30, 2024	CI
25/05/24	Procyon Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2019	2020	2021	2022	2023	2024
Market Cap ¹	1.796	1.925	3.013	3.801	2.022	1.868
Change	-	7.16%	56.51%	26.17%	-46.81%	-7.62%
Enterprise Value (EV) ¹	1.352	1.339	2.352	3.454	1.594	1.386
Change	-	-0.99%	75.72%	46.84%	-53.84%	-13.1%
P/E	180x	23.8x	4.14x	-15.7x	-25x	-5.75x
PBR	0.93x	0.94x	1.07x	1.5x	0.81x	0.86x
PEG	-	0x	0x	0x	0.4x	-0x
Capitalization / Revenue	0.43x	0.44x	0.64x	0.78x	0.43x	0.37x
EV / Revenue	0.32x	0.31x	0.5x	0.71x	0.34x	0.28x
EV / EBITDA	9.03x	6.47x	6.39x	-17.4x	-35.8x	-9.24x
EV / EBIT	13.9x	8.75x	7.24x	-14.6x	-16.4x	-5.98x
EV / FCF	-25.4x	18.9x	10.2x	-11.6x	6.93x	-28.2x
FCF Yield	-3.93%	5.28%	9.79%	-8.63%	14.4%	-3.55%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.001233	0.01	0.09	-0.03	-0.01	-0.04
Distribution rate	-	-	-	-	-	-
Net sales ¹	4.191	4.334	4.72	4.842	4.687	4.984
EBITDA ¹	0.1497	0.207	0.3681	-0.199	-0.0446	-0.15
EBIT ¹	0.0971	0.153	0.3248	-0.2372	-0.0974	-0.2317
Net income ¹	0.0272	0.1117	0.7676	-0.2098	-0.0502	-0.3411
Net Debt ¹	-0.4442	-0.5862	-0.6605	-0.3472	-0.4275	-0.4821
Reference price ²	0.2221	0.2380	0.3725	0.4700	0.2500	0.2300
Nbr of stocks (in thousands)	8,087	8,087	8,087	8,087	8,087	8,120
Announcement Date	9/30/19 A	10/6/20 A	10/8/21 A	9/28/22 A	9/28/23 A	10/25/24 A

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
PROCYON CORPORATION	-	-	-	-	1.48M
ELI LILLY AND COMPANY	41.32x	13.98x	29.71x	0.48%	1,258B
JOHNSON & JOHNSON	41.29x	6.93x	19.48x	1.89%	679B
ABBVIE INC.	37.78x	8.57x	17.7x	2.35%	518B
ROCHE HOLDING AG	21.56x	5.23x	13.1x	2.5%	390B
MERCK & CO., INC.	105.59x	6.02x	25.64x	2.28%	367B
NOVARTIS AG	23.81x	5.93x	14.32x	2.69%	307B
ASTRAZENECA PLC	24.64x	4.94x	13.88x	1.76%	293B
AMGEN INC.	24x	7.37x	13.68x	2.17%	252B
GILEAD SCIENCES, INC.	-39.75x	7.37x	46.38x	1.95%	210B
Average	31.14x	7.37x	21.54x	2.01%	427B
Weighted average by Cap.	37.19x	8.81x	22.45x	1.69%